title: Novel approach to ischemic skin ulcer in systemic lupus erythematosus: therapeutic angiogenesis by controlled-release basic fibroblast growth factor.
authors.forename: Shuhei
authors.initials: S
authors.lastname: Tara
authors.forename: Gen
authors.initials: G
authors.lastname: Takagi
authors.forename: Masaaki
authors.initials: M
authors.lastname: Miyamoto
authors.forename: Sonoko
authors.initials: S
authors.lastname: Kirinoki-Ichikawa
authors.forename: Teppei
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takano
authors.forename: Ikuyo
authors.initials: I
authors.lastname: Takagi
authors.forename: Masahiro
authors.initials: M
authors.lastname: Yasutake
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Tabata
authors.forename: Kyoichi
authors.initials: K
authors.lastname: Mizuno
mesh_terms: D000368:Aged; D015901:Angiography, Digital Subtraction; D003692:Delayed-Action Preparations; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D005528:Foot; D006801:Humans; D007511:Ischemia / Q000188:drug therapy* / Q000209:etiology*; D007866:Leg / Q000098:blood supply / Q000000981:diagnostic imaging; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D003692:Delayed-Action Preparations; D016222:Fibroblast Growth Factor 2